Results 141 to 150 of about 142,289 (185)

Correction: A bibliometric analysis and systematic review of drug repurposing against drug-resistant ESKAPE pathogens: a particular focus on <i>Pseudomonas aeruginosa</i>. [PDF]

Front Microbiol
Frontiers Production Office.
europepmc   +1 more source

Drug Repurposing for Inclusion of COVID-19-Related Indication: Field Study of the European Medicines Agency's Response to the Pandemic. [PDF]

Pharmacy (Basel)
Ivanov A, Getova-Kolarova V, Hababa-Ivanova I.   +2 more
europepmc   +1 more source

Overcoming barriers to off-patent drug repurposing: a lifecycle-based policy solutions. [PDF]

Front Pharmacol
Garcia-Diaz M, Epstein D, Espin J.
europepmc   +1 more source

High-Throughput Screening of FDA-Approved Drugs for Antibacterial and Antibiofilm Activities Against Multidrug-resistant <i>Pseudomonas aeruginosa</i>. [PDF]

ACS Omega
Guo S, Li H, Liu B, Chen C, Liu H, Zhang Q.   +5 more
europepmc   +1 more source

Brief comments on "Perturbation response scanning of drug-target networks: Drug repurposing for multiple sclerosis". [PDF]

J Pharm Anal
Giuliani A.
europepmc   +1 more source

Evaluating the Role of Machine Learning and Artificial Intelligence in Oncology Drug Repurposing Efforts. [PDF]

J Res Pharm Pract
Mann A.
europepmc   +1 more source

Harnessing Single-Cell RNA-Seq for Computational Drug Repurposing in Cancer Immunotherapy. [PDF]

Pharmaceuticals (Basel)
Cheng OJ, Tran TTT, Chen YA, Tan AC.
europepmc   +1 more source